Rite Aid Isopropyl Alcohol Prep Pads Recalled for Below-Labeled Concentration
Rite Aid pharmacy isopropyl alcohol prep pads distributed nationwide are being recalled because the alcohol concentration falls below the labeled level. The FDA classified this Class II recall because reduced potency may affect the product's antimicrobial effectiveness.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall without any reported illnesses, injuries, or hospitalizations. The hazard is subpotency—reduced effective concentration—rather than contamination or toxicity, affecting a low-risk topical over-the-counter product.
Plain-English summary
Medline Industries, LP is recalling approximately 984,000 Rite Aid pharmacy first aid alcohol prep pads distributed nationwide. The product is sold under NDC number 11822-5156-2 with code 61224070083.
The FDA classified this as a Class II recall because the isopropyl alcohol concentration in the affected pads falls below the labeled concentration. This means the product may not provide the antimicrobial protection consumers expect.
Consumers who have purchased these prep pads should discontinue use and contact Rite Aid or speak with their healthcare provider if they have questions about the effectiveness of any products they may have used.
The recalled product
- Product
- ALCOHOL (ISOPROPYL ALCOHOL)
- Brand
- ALCOHOL
- Manufacturer
- MEDLINE INDUSTRIES, LP - Northfield
- Category
- Drug — OTC Antiseptic
- Hazard
- subpotency
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 61224070083
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ALCOHOL
- ModerateAntiseptic Alcohol Swabs Recalled Due to Improper Storage Conditions
FDA (Drugs) · 2022-08-17
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27